Biblio Discovery — Demo Discovery Service

7 hasil untuk "Hind AlHumaidan"

Menampilkan 1–7 · 0,23 detik · RSS

  1. Artikel Jurnal

    Voluntary and non‐voluntary blood donations among doctors

    Rana Ahmed Saleh; Hala Khalil; Mahasen Alsaleh dkk.

    Health Science Reports, Vol. 4 No. 4 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Physicians may be an important source of blood donations as they are more likely to be familiar with the importance of donating and the donation process. The aim of this study is to report physicians' knowledge, attitudes, and practices towards voluntary and non‐voluntary blood…

  2. Artikel Jurnal

    Assessing Iron-deficiency Anemia among Female University Students in a Single Center

    Hind AlHumaidan; Wasaef Alharbi; Ayomi Jayathilake dkk.

    Journal of Applied Hematology, Vol. 17 No. 2 · 2026 · Inggris · DOAJ Scopus

    BACKGROUND: Gynecological and nutritional factors are key contributors to the development of iron deficiency anemia (IDA) in women. OBJECTIVE: This study was conducted to assess IDA among female university students in Saudi Arabia. DESIGN: Cross-sectional study. SETTING: University. PATIENTS AND…

  3. Artikel Jurnal

    Management and clinical outcomes of patients with homozygous familial hypercholesteremia in Saudi Arabia

    Naji Kholaif; Tahir I. Mohamed; Ibrahim S. Alharbi dkk.

    Monaldi Archives for Chest Disease (2023) · 2023 · Inggris · DOAJ Scopus

    We report the incidence, patient characteristic with clinical outcomes in patients with homozygous familial hypercholesterolemia (HoFH) in Saudi Arabia. This is a retrospective and prospective, single center study which included 37 patients 14 years and older enrolled and followed up between…

  4. Artikel Jurnal

    ABO incompatible kidney transplantation: the Saudi experience

    Tariq Ali; Dieter Broering; Hassan Aleid dkk.

    Saudi Journal of Kidney Diseases and Transplantation, Vol. 30 No. 3 · 2019 · Inggris · DOAJ Scopus

    Although the outcomes of ABO-incompatible (ABOi) kidney transplant recipients are quite favorable, these patients are at increased risk of early antibody-mediated rejection (AMR) and graft loss. Some studies have also shown high mortality in the ABOi group mainly due to increased risk of…

  5. Artikel Jurnal

    ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities

    Mohammad Shagrani, MD; Kishwer Kumar, MD; Alastair Baker, MD dkk.

    Transplantation Direct, Vol. 8 No. 12 · 2022 · Inggris · DOAJ Scopus

    Background. The success of orthotopic liver transplantation as a life-saving treatment has led to new indications and a greater competition for organ grafts. Pediatric patients with acute liver-related crises can benefit from orthotopic liver transplantation, but organ availability in the limited…

  6. Artikel Jurnal

    Hematopoietic stem cell transplantation in Saudi Arabia between 1984 and 2016: Experience from four leading tertiary care hematopoietic stem cell transplantation centers

    Marwan Shaheen; Fahad Almohareb; Naif Aljohani dkk.

    Hematology/Oncology and Stem Cell Therapy, Vol. 14 No. 3 · 2021 · Inggris · DOAJ Scopus

    Saudi Arabia is the largest of the Arabian Gulf countries with a total population of 33.41 million as of 2017. This report summarizes the experience from four leading tertiary care hematopoietic stem cell transplantation (HSCT) centers in Saudi Arabia representing more than 90% of all HSCTs…

  7. Artikel Jurnal

    Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia

    Nawal AlShehry; Syed Ziauddin A Zaidi; Ahmed AlAskar dkk.

    Saudi Journal of Medicine and Medical Sciences, Vol. 9 No. 1 · 2021 · Inggris · DOAJ Scopus

    Objective: To present the interim findings from a national study investigating the safety and efficacy of convalescent plasma (CP) containing detectable IgG antibodies as a treatment strategy for severe coronavirus disease 2019 (COVID-19). Trial Design and Participants: An open label, two-arm…